A Clinical Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin

Clinical trial NCT06716645 · COMPLETED

Trial details

NCT number: NCT06716645
Sponsor: HALEON
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Common Cold Cough

Start date: 2024-12-04
Primary completion: 2025-02-14
Enrollment: 244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.